Fundraising Fox
/Companies
Sign in

Otomagnetics

Rockville, US · Founded 2012 · Delaware corporation · 6 employees on LinkedIn · 1 known investors

Find your way into Otomagnetics

Sign up to see every warm intro you have to Otomagnetics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Otomagnetics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Otomagnetics develops a non-invasive magnetic injection system to deliver drugs and therapeutic payloads to the inner and middle ear, the eye, and the skin, aimed at treating conditions such as inner ear diseases. The technology has demonstrated drug delivery to the inner and middle ear in animal models without puncturing the eardrum.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

DB
David BeylinNamed on SEC filing
TP
Ting Pau OeiNamed on SEC filing
BS
Benjamin ShapiroNamed on SEC filing

Investors · 1

AngelMDreportedDenver

How we know: funding news · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

$1.3M disclosed across 2 of 3 rounds · 2017–2020

▶$1MraisedMar 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Neela ChipalkattyDirector
  • Irving WeinbergDirector
  • David BeylinDirector
  • Benjamin ShapiroExecutive Officer, Director
  • Abhita BatraExecutive Officer, Director
Offering amount
$3.4M
Amount sold
$1M
Minimum investment
$1K
Proceeds to insiders
$250K
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$260KraisedJul 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David BeylinExecutive Officer, Director
  • Ting Pau OeiExecutive Officer, Director
  • Benjamin ShapiroExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$260K
Minimum investment
$25K
Proceeds to insiders
$328K
First sale
Jul 2017
Incorporated
Limited Liability Company, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

OtoNexusOtoNexus Medical Technologies is developing an ultrasound-based otoscope (Novoscope) that uses a miniaturized sensor in a single-use ear speculum tip to give clinicians objective, point-of-care data on middle-ear fluid and infection type. The device targets pediatric otitis media diagnosis to support antibiotic stewardship and reduce misdiagnosis for physicians, hospitals, and payers.

Companies working in the same space as Otomagnetics.

Frequently asked questions

What does Otomagnetics do?
Otomagnetics develops a non-invasive magnetic injection system to deliver drugs and therapeutic payloads to the inner and middle ear, the eye, and the skin, aimed at treating conditions such as inner ear diseases. The technology has demonstrated drug delivery to the inner and middle ear in animal models without puncturing the eardrum.
Who are Otomagnetics's investors?
Otomagnetics's investors include AngelMD.
How much funding has Otomagnetics raised?
Otomagnetics has disclosed $1.3M raised across 2 of its 3 known rounds.
Where is Otomagnetics headquartered?
Otomagnetics is headquartered in Rockville, US.